Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: Anacor Pharmaceuticals Prices $20 Million Public Offering of Common Stock to ANADIGICS Announces First Quarter 2013 Results

This site contains about 74,006 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   30   40   50   60   70   80   90   100   110   116   117   118   119   120   121   122   123   124   125   126   127   128   129   130   131   132   133   134   135   136   137   138   139   140   141   142   143   144   145   150   160   170   180   190   200   210   220   230   300   400   500   600   700   800   900   1,000   1,100   2,000   2,467 

2013/4/26
Anacor Pharmaceuticals Prices $20 Million Public Offering of Common Stock
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that it has priced an underwritten public offering of 3,129,890 shares of its common stock at a price to the public of $6.39 per share for gross proceeds of $20.0 million.
View more Anacor Pharmaceuticals Prices $20 Million Public Offering of Common Stock analysis
Sign-up for Anacor Pharmaceuticals Prices $20 Million Public Offering of Common Stock investment picks
2013/5/2
Anacor Pharmaceuticals Provides Update Regarding Arbitration With Valeant Pharmaceuticals
Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that Valeant Pharmaceuticals International, Inc., or Valeant, has agreed that the launch of efinaconazole, its topical product candidate for the treatment of onychomycosis, will not occur until after the September 2013 arbitration hearing to resolve our breach of contract dispute with Valeant.
View more Anacor Pharmaceuticals Provides Update Regarding Arbitration With Valeant Pharmaceuticals analysis
Sign-up for Anacor Pharmaceuticals Provides Update Regarding Arbitration With Valeant Pharmaceuticals investment picks
2013/4/8
Anacor Pharmaceuticals Receives Significant Investment to Support Neglected Disease Research
Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis (TB). Additionally, Anacor will create an expanded library of boron compounds to screen for additional potential drug candidates to treat neglected diseases and will provide access to the expanded library compounds for neglected disease research to the Gates Foundation, and others, including academic, governmental and other non-profit institutions or equivalent entities.
View more Anacor Pharmaceuticals Receives Significant Investment to Support Neglected Disease Research analysis
Sign-up for Anacor Pharmaceuticals Receives Significant Investment to Support Neglected Disease Research investment picks
2013/3/14
Anacor Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the fourth quarter and year ended December 31, 2012.
View more Anacor Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results analysis
Sign-up for Anacor Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results investment picks
2013/5/9
Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the first quarter ended March 31, 2013.
View more Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results analysis
Sign-up for Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results investment picks
2013/3/20
Anacor Pharmaceuticals to Hold Conference Call Tomorrow, March 21, 2013 at 8am ET / 5am PT to Discuss Preliminary Results From the Phase 2 Dose-Ranging Study of AN2728 in the Treatment of Adolescents With Atopic Dermatitis
Anacor Pharmaceuticals (NASDAQ:ANAC) will release preliminary results from the Phase 2 dose-ranging study of AN2728 in the treatment of adolescents with atopic dermatitis tomorrow, March 21, 2013 at approximately 7:00 a.m. ET.
View more Anacor Pharmaceuticals to Hold Conference Call Tomorrow, March 21, 2013 at 8am ET / 5am PT to Discuss Preliminary Results From the Phase 2 Dose-Ranging Study of AN2728 in the Treatment of Adolescents With Atopic Dermatitis analysis
Sign-up for Anacor Pharmaceuticals to Hold Conference Call Tomorrow, March 21, 2013 at 8am ET / 5am PT to Discuss Preliminary Results From the Phase 2 Dose-Ranging Study of AN2728 in the Treatment of Adolescents With Atopic Dermatitis investment picks
2013/5/23
Anacor Pharmaceuticals to Present at Deutsche Bank’s 38th Annual Healthcare Conference
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at Deutsche Bank’s 38 th Annual Healthcare Conference on Thursday, May 30, 2013 at 2:10 p.m. ET in Boston, Massachusetts.
View more Anacor Pharmaceuticals to Present at Deutsche Bank’s 38th Annual Healthcare Conference analysis
Sign-up for Anacor Pharmaceuticals to Present at Deutsche Bank’s 38th Annual Healthcare Conference investment picks
2013/2/25
Anacor Pharmaceuticals to Present at the Cowen 33rd Annual Healthcare Conference
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Cowen 33 rd Annual Healthcare Conference on Monday, March 4, 2013 at 4:50 p.m. ET in Boston, Massachusetts.
View more Anacor Pharmaceuticals to Present at the Cowen 33rd Annual Healthcare Conference analysis
Sign-up for Anacor Pharmaceuticals to Present at the Cowen 33rd Annual Healthcare Conference investment picks
2013/5/6
Anadarko 1st-Quarter Profit Fell 79% Amid Year Earlier Gain
Anadarko Petroleum Corp.'s (APC) first-quarter earnings fell 79% as the year-earlier period included a $1.8 billion benefit related to the resolution of an Algeria tax dispute.
View more Anadarko 1st-Quarter Profit Fell 79% Amid Year Earlier Gain analysis
Sign-up for Anadarko 1st-Quarter Profit Fell 79% Amid Year Earlier Gain investment picks
2013/3/5
Anadarko Announces $860 Million Carried-Interest Agreement for Heidelberg Development
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993187&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Announces $860 Million Carried-Interest Agreement for Heidelberg Development analysis
Sign-up for Anadarko Announces $860 Million Carried-Interest Agreement for Heidelberg Development investment picks
2013/2/4
Anadarko Announces 2012 Fourth-Quarter and Full-Year Results
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981666&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Announces 2012 Fourth-Quarter and Full-Year Results analysis
Sign-up for Anadarko Announces 2012 Fourth-Quarter and Full-Year Results investment picks
2013/2/20
Anadarko Announces 2013 Capital Program and Guidance
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987885&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Announces 2013 Capital Program and Guidance analysis
Sign-up for Anadarko Announces 2013 Capital Program and Guidance investment picks
2013/5/6
Anadarko Announces First-Quarter 2013 Results
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014101&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Announces First-Quarter 2013 Results analysis
Sign-up for Anadarko Announces First-Quarter 2013 Results investment picks
2013/4/25
Anadarko Announces Phobos Discovery in the Deepwater Gulf of Mexico
http://media.marketwire.com/attachments/201304/TN-60252_GulfOfMexicoPhobos.jpg Anadarko Phobos discovery in the deepwater Gulf of Mexico.
View more Anadarko Announces Phobos Discovery in the Deepwater Gulf of Mexico analysis
Sign-up for Anadarko Announces Phobos Discovery in the Deepwater Gulf of Mexico investment picks
2013/5/28
Anadarko Announces Promotion of Jim Kleckner
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1021134&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Announces Promotion of Jim Kleckner analysis
Sign-up for Anadarko Announces Promotion of Jim Kleckner investment picks
2013/3/19
Anadarko Announces Shenandoah Appraisal Well Encounters More Than 1,000 Net Feet of Oil Pay
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://media.marketwire.com/attachments/201303/TN-58726_APCShenandoahBasinMap3-19-13.pdf.jpg Shenandoah Basin http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=998434&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Announces Shenandoah Appraisal Well Encounters More Than 1,000 Net Feet of Oil Pay analysis
Sign-up for Anadarko Announces Shenandoah Appraisal Well Encounters More Than 1,000 Net Feet of Oil Pay investment picks
2013/2/14
Anadarko Declares Dividend
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986130&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Declares Dividend analysis
Sign-up for Anadarko Declares Dividend investment picks
2013/5/14
Anadarko Declares Dividend
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1017451&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Declares Dividend analysis
Sign-up for Anadarko Declares Dividend investment picks
2013/4/18
Anadarko Discovers New Natural-Gas Field Offshore Mozambique
Anadarko Petroleum Corp.
View more Anadarko Discovers New Natural-Gas Field Offshore Mozambique analysis
Sign-up for Anadarko Discovers New Natural-Gas Field Offshore Mozambique investment picks
2013/4/18
Anadarko Provides East Africa Exploration Update
http://media.marketwire.com/attachments/201304/TN-59909_APCOrcaDiscovery4-18-13.pdf.jpg Anadarko's Orca natural gas discovery, located in Mozambique's Offshore Area 1 http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1008471&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Provides East Africa Exploration Update analysis
Sign-up for Anadarko Provides East Africa Exploration Update investment picks
2013/1/31
Anadarko Ranks Among Nation's Top Workplaces for Second Consecutive Year
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980519&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Ranks Among Nation's Top Workplaces for Second Consecutive Year analysis
Sign-up for Anadarko Ranks Among Nation's Top Workplaces for Second Consecutive Year investment picks
2013/4/16
Anadarko Schedules First-Quarter 2013 Earnings Conference Call for May 7
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1007700&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko Schedules First-Quarter 2013 Earnings Conference Call for May 7 analysis
Sign-up for Anadarko Schedules First-Quarter 2013 Earnings Conference Call for May 7 investment picks
2013/2/4
Anadarko to Host Investor Conference Call on Feb. 20, 2013
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981689&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko to Host Investor Conference Call on Feb. 20, 2013 analysis
Sign-up for Anadarko to Host Investor Conference Call on Feb. 20, 2013 investment picks
2013/3/1
Anadarko to Present at Upcoming Conference
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=992093&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko to Present at Upcoming Conference analysis
Sign-up for Anadarko to Present at Upcoming Conference investment picks
2013/5/13
Anadarko to Present at Upcoming Energy Conference
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016769&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko to Present at Upcoming Energy Conference analysis
Sign-up for Anadarko to Present at Upcoming Energy Conference investment picks
2013/2/1
Anadarko to Present at Upcoming Energy Summit
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981219&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko to Present at Upcoming Energy Summit analysis
Sign-up for Anadarko to Present at Upcoming Energy Summit investment picks
2013/5/20
Anadarko to Present at Upcoming Oil & Gas Conference
http://media.marketwire.com/attachments/201008/10984_anadarko.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1019097&ProfileId=051205&sourceType=1 HOUSTON, TX --
View more Anadarko to Present at Upcoming Oil & Gas Conference analysis
Sign-up for Anadarko to Present at Upcoming Oil & Gas Conference investment picks
2013/4/25
Anadarko Well Hits New Deep Water Gulf of Mexico Oil Discovery
Anadarko Petroleum Corp.
View more Anadarko Well Hits New Deep Water Gulf of Mexico Oil Discovery analysis
Sign-up for Anadarko Well Hits New Deep Water Gulf of Mexico Oil Discovery investment picks
2013/4/15
ANADIGICS Announces Date of First Quarter Earnings Release and Conference Call Information
WARREN, N.J., April 15, 2013 (GLOBE NEWSWIRE) -- ANADIGICS, Inc. (Nasdaq:ANAD) , a leading provider of semiconductor solutions in the broadband wireless and wireline communications markets, today announced that it will release its first quarter 2013 results on April 29, 2013 at approximately 4:00 pm Eastern Time.
View more ANADIGICS Announces Date of First Quarter Earnings Release and Conference Call Information analysis
Sign-up for ANADIGICS Announces Date of First Quarter Earnings Release and Conference Call Information investment picks
2013/4/29
ANADIGICS Announces First Quarter 2013 Results
Net Sales of $26.4 Million GAAP EPS ($0.26); Non-GAAP EPS ($0.20) WARREN, N.J., April 29, 2013 (GLOBE NEWSWIRE) -- ANADIGICS, Inc. (Nasdaq:ANAD) , a leading provider of semiconductor solutions in the broadband wireless and wireline communications markets, reported first quarter 2013 net sales of $26.4 million, a decrease of 13.4% sequentially and 7.2% from the first quarter of 2012.
View more ANADIGICS Announces First Quarter 2013 Results analysis
Sign-up for ANADIGICS Announces First Quarter 2013 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: Anacor Pharmaceuticals Prices $20 Million Public Offering of Common Stock to ANADIGICS Announces First Quarter 2013 Results
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.